First Time Loading...

OPKO Health Inc
NASDAQ:OPK

Watchlist Manager
OPKO Health Inc Logo
OPKO Health Inc
NASDAQ:OPK
Watchlist
Price: 1.3 USD Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

OPK Price Targets Summary
OPKO Health Inc

Wall Street analysts forecast OPK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OPK is 4.34 USD with a low forecast of 1.52 USD and a high forecast of 8.93 USD.

OPK Lowest Forecast
Wall Street Target
1.52 USD
17% Upside
OPK Average Forecast
Wall Street Target
4.34 USD
233% Upside
OPK Highest Forecast
Wall Street Target
8.93 USD
587% Upside
Lowest
Price Target
1.52 USD
17% Upside
Average
Price Target
4.34 USD
233% Upside
Highest
Price Target
8.93 USD
587% Upside
OPKO Health Inc Competitors:
Price Targets
MGNX
MacroGenics Inc
61% Upside
B
600161
Beijing Tiantan Biological Products Corp Ltd
16% Upside
AFMD
Affimed NV
323% Upside
W
300142
Walvax Biotechnology Co Ltd
39% Upside
MGNX
MacroGenics Inc
61% Upside
B
600161
Beijing Tiantan Biological Products Corp Ltd
16% Upside
AFMD
Affimed NV
323% Upside
W
300142
Walvax Biotechnology Co Ltd
39% Upside
A
APGE
Apogee Therapeutics Inc
61% Upside
ARWR
Arrowhead Pharmaceuticals Inc
131% Upside
GILD
Gilead Sciences Inc
30% Upside
S
688180
Shanghai Junshi Biosciences Co Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
OPKO Health Inc

For the last 8 years the compound annual growth rate for OPKO Health Inc's revenue is 7%. The projected CAGR for the next 3 years is 3%.

7%
Past Growth
3%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
OPKO Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
OPKO Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
What are analyst estimates?

See Also

Summary
OPK intrinsic value, competitors valuation, and company profile.
DCF Valuation
OPK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OPK stock valuation using valuation multiples.
Wall Street Estimates
OPK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OPK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OPK's stock price target?
Price Target
4.34 USD

According to Wall Street analysts, the average 1-year price target for OPK is 4.34 USD with a low forecast of 1.52 USD and a high forecast of 8.93 USD.

What is OPKO Health Inc's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for OPKO Health Inc's revenue is 7%. The projected CAGR for the next 3 years is 3%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.